220 related articles for article (PubMed ID: 25007546)
1. [The impact of psilocybin on visual perception and spatial orientation--neuropsychological approach].
Jastrzebski M; Bala A
Psychiatr Pol; 2013; 47(6):1157-67. PubMed ID: 25007546
[TBL] [Abstract][Full Text] [Related]
2. Effects of psilocybin on time perception and temporal control of behaviour in humans.
Wittmann M; Carter O; Hasler F; Cahn BR; Grimberg U; Spring P; Hell D; Flohr H; Vollenweider FX
J Psychopharmacol; 2007 Jan; 21(1):50-64. PubMed ID: 16714323
[TBL] [Abstract][Full Text] [Related]
3. Effects of the hallucinogen psilocybin on covert orienting of visual attention in humans.
Gouzoulis-Mayfrank E; Thelen B; Maier S; Heekeren K; Kovar KA; Sass H; Spitzer M
Neuropsychobiology; 2002; 45(4):205-12. PubMed ID: 12097810
[TBL] [Abstract][Full Text] [Related]
4. The pharmacology of psilocybin.
Passie T; Seifert J; Schneider U; Emrich HM
Addict Biol; 2002 Oct; 7(4):357-64. PubMed ID: 14578010
[TBL] [Abstract][Full Text] [Related]
5. A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students.
Hallock RM; Dean A; Knecht ZA; Spencer J; Taverna EC
Drug Alcohol Depend; 2013 Jun; 130(1-3):245-8. PubMed ID: 23265089
[TBL] [Abstract][Full Text] [Related]
6. [Hallucinogenic fungi (psilocybe). Part II. Identification of Psilocybe semilanceata by PCR].
Adamczyk A; Sadakierska-Chudy A; Janoszka J; Rymkiewicz A; Dobosz T
Arch Med Sadowej Kryminol; 2007; 57(3):285-8. PubMed ID: 17907620
[TBL] [Abstract][Full Text] [Related]
7. [Hallucinogenic mushrooms].
Reingardiene D; Vilcinskaite J; Lazauskas R
Medicina (Kaunas); 2005; 41(12):1067-70. PubMed ID: 16401965
[TBL] [Abstract][Full Text] [Related]
8. Hallucinogenic mushrooms on the German market - simple instructions for examination and identification.
Musshoff F; Madea B; Beike J
Forensic Sci Int; 2000 Sep; 113(1-3):389-95. PubMed ID: 10978653
[TBL] [Abstract][Full Text] [Related]
9. [Automutilation after consumption of hallucinogenic mushrooms].
Attema-de Jonge ME; Portier CB; Franssen EJ
Ned Tijdschr Geneeskd; 2007 Dec; 151(52):2869-72. PubMed ID: 18257429
[TBL] [Abstract][Full Text] [Related]
10. Psilocybin--summary of knowledge and new perspectives.
Tylš F; Páleníček T; Horáček J
Eur Neuropsychopharmacol; 2014 Mar; 24(3):342-56. PubMed ID: 24444771
[TBL] [Abstract][Full Text] [Related]
11. Dose-response relationships of psilocybin-induced subjective experiences in humans.
Hirschfeld T; Schmidt TT
J Psychopharmacol; 2021 Apr; 35(4):384-397. PubMed ID: 33663259
[TBL] [Abstract][Full Text] [Related]
12. Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies.
Studerus E; Kometer M; Hasler F; Vollenweider FX
J Psychopharmacol; 2011 Nov; 25(11):1434-52. PubMed ID: 20855349
[TBL] [Abstract][Full Text] [Related]
13. [Hallucinogenic mushrooms in Denmark].
Holm JW; Ebbehøj NE; Fjeldberg IA
Ugeskr Laeger; 1997 Aug; 159(34):5116-8. PubMed ID: 9297322
[No Abstract] [Full Text] [Related]
14. [Psychoactive mushrooms - an update].
Supprian T; Frey U; Supprian R; Rösler M; Wanke K
Fortschr Neurol Psychiatr; 2001 Dec; 69(12):597-602. PubMed ID: 11753749
[TBL] [Abstract][Full Text] [Related]
15. [Levels of psilocybin and psilocin in various types of mushrooms].
Stríbrný J; Borovicka J; Sokol M
Soud Lek; 2003 Jul; 48(3):45-9. PubMed ID: 14631713
[TBL] [Abstract][Full Text] [Related]
16. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.
Vollenweider FX; Vollenweider-Scherpenhuyzen MF; Bäbler A; Vogel H; Hell D
Neuroreport; 1998 Dec; 9(17):3897-902. PubMed ID: 9875725
[TBL] [Abstract][Full Text] [Related]
17. Effects of varied doses of psilocybin on time interval reproduction in human subjects.
Wackermann J; Wittmann M; Hasler F; Vollenweider FX
Neurosci Lett; 2008 Apr; 435(1):51-5. PubMed ID: 18325673
[TBL] [Abstract][Full Text] [Related]
18. A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment.
Burdick BV; Adinoff B
Am J Drug Alcohol Abuse; 2013 Sep; 39(5):291-7. PubMed ID: 23968172
[TBL] [Abstract][Full Text] [Related]
19. [Consumption of psilocybin-containing hallucinogenic mushrooms by young people].
Lassen JF; Lassen NF; Skov J
Ugeskr Laeger; 1992 Sep; 154(39):2678-81. PubMed ID: 1413197
[TBL] [Abstract][Full Text] [Related]
20. Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers.
Johnson MW; Sewell RA; Griffiths RR
Drug Alcohol Depend; 2012 Jun; 123(1-3):132-40. PubMed ID: 22129843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
